PIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings

James S. Leathers, Domingo Balderramo, Jhon Prieto, Fernando Diehl, Esteban Gonzalez-Ballerga, Melina R. Ferreiro, Enrique Carrera, Fernando Barreyro, Javier Diaz-Ferrer, Dupinder Singh, Angelo Z. Mattos, Flair Carrilho, Jose D. Debes

Research output: Contribution to journalArticlepeer-review

1 Scopus citations
Original languageEnglish (US)
Article numbere82345
JournalHepatitis Monthly
Issue number10
StatePublished - Oct 2018

Bibliographical note

Funding Information:
Supported in part by the Doris Duke charitable foundation through a grant supporting the Doris Duke international clinical research fellows program and the Robert Wood Johnson foundation.


  • HCC
  • Hepatocellular carcinoma
  • Score
  • Sorafenib

Cite this